HIV-1 Neutralization: Mechanisms and Relevance to Vaccine Design

Author(s): Michael B. Zwick, Dennis R. Burton

Journal Name: Current HIV Research
HIV and Viral Immune Diseases

Volume 5 , Issue 6 , 2007

Become EABM
Become Reviewer
Call for Editor


Antibody (Ab) mediated neutralization is a crucial means of host resistance to many pathogens and will most likely be required in the development of a vaccine to protect against HIV-1. Here we examine mechanistic aspects of HIV-1 neutralization with attention to recent studies on the stoichiometric, kinetic and thermodynamic parameters involved. Neutralization of HIV-1, as with any microbe, minimally requires an initial molecular encounter with Ab. Ab occupancy of functional heterotrimers of the envelope glycoproteins, gp120 and gp41 (Env), indeed appears to be the dominant mechanism of neutralization for HIV-1. However, the Ab-binding site, the parameters mentioned above, as well as the stages and duration of vulnerability to Ab recognition, prior to and leading up to viral entry, each have a distinct impact on the mechanism of neutralization for any given Ab specificity. With HIV-1, the problems of mutational variation and neutralization resistance, coupled with the lability and conformational heterogeneity in Env, have stimulated the search for rational approaches to Env immunogen design that are unprecedented in vaccinology.

Keywords: Neutralization mechanism, antibodies, vaccine development, virus fusion

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [608 - 624]
Pages: 17
DOI: 10.2174/157016207782418443
Price: $65

Article Metrics

PDF: 6